Compare Abbott Laboratories (ABT) vs Iron Mountain Inc (IRM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Iron Mountain Inc — how do they compare? Abbott Laboratories trades at $95.76 (market cap $166.94B), while Iron Mountain Inc trades at $114.47 (market cap $34.44B). The key difference: Abbott Laboratories is far larger — about 4.8× Iron Mountain Inc's market cap, and Iron Mountain Inc pays the higher dividend (2.99%). Which is the better fit depends on your goals.
| ABT | IRM | |
|---|---|---|
Market Cap | $166.94B | $34.44B |
Sector | Health | Real Estate |
52-Week High | $136.62 | $133.06 |
52-Week Low | $82.57 | $78.86 |
Enterprise Value | $193.69B | $53.57B |
Dividend Yield | 2.63% | 2.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Iron Mountain (IRM) trades at $115.75, down 1.2% on the day, with strong recent earnings beats and a bullish analyst consensus of $138.67 price target. The stock shows technical bearish signals despite positive momentum news, while fundamentals reveal modest revenue growth to $6.90B in 2025 but declining net margins to 3.76%. Recent debt offerings of $1.5B highlight capital strategy moves amid high leverage.
Outlook remains cautiously optimistic given earnings outperformance and industry tailwinds, but risks include elevated debt levels and margin pressure. The stock offers growth potential with a 65% buy rating from analysts, though investors should weigh technical weakness against fundamental resilience in the information services sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →
